Brain-on-a-chip technology reveals how sepsis and neurodegenerative diseases damage the brain

In lieu of animal experiments, researchers from the University of Rochester are using state-of-the-art microchips with human ...

BrYet US, Inc. Receives Approval to Initiate in Australia a First-in-Human Phase 1/2 Trial ...

HOUSTON, TX and SUNSHINE COAST, QUEENSLAND / ACCESS Newswire / October 6, 2025 / BrYet US, Inc. (“BrYet”), a biotechnology innovator developing a drug with the potential to be a first-in-class ...